Global Pentavalent Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Pentavalent Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).
This report is a detailed and comprehensive analysis for global Pentavalent Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pentavalent Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pentavalent Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pentavalent Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd. and Novartis AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Pentavalent Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Pentavalent Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pentavalent Vaccine, with price, sales, revenue and global market share of Pentavalent Vaccine from 2018 to 2023.
Chapter 3, the Pentavalent Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pentavalent Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pentavalent Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pentavalent Vaccine.
Chapter 14 and 15, to describe Pentavalent Vaccine sales channel, distributors, customers, research findings and conclusion.
A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).
This report is a detailed and comprehensive analysis for global Pentavalent Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pentavalent Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Pentavalent Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pentavalent Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pentavalent Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd. and Novartis AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Pentavalent Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Lyophilized
- Liquid
- Retail Pharmacy
- Hospital Pharmacy
- E-commerce
- Serum Institute of India
- Panacea Drugs Pvt. Ltd
- Shantha Biotechnics
- Biological E. Ltd.
- Novartis AG
- Crucell
- Bio Farma
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Pentavalent Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pentavalent Vaccine, with price, sales, revenue and global market share of Pentavalent Vaccine from 2018 to 2023.
Chapter 3, the Pentavalent Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pentavalent Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pentavalent Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pentavalent Vaccine.
Chapter 14 and 15, to describe Pentavalent Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Pentavalent Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pentavalent Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Lyophilized
1.3.3 Liquid
1.4 Market Analysis by Application
1.4.1 Overview: Global Pentavalent Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Retail Pharmacy
1.4.3 Hospital Pharmacy
1.4.4 E-commerce
1.5 Global Pentavalent Vaccine Market Size & Forecast
1.5.1 Global Pentavalent Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pentavalent Vaccine Sales Quantity (2018-2029)
1.5.3 Global Pentavalent Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Serum Institute of India
2.1.1 Serum Institute of India Details
2.1.2 Serum Institute of India Major Business
2.1.3 Serum Institute of India Pentavalent Vaccine Product and Services
2.1.4 Serum Institute of India Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Serum Institute of India Recent Developments/Updates
2.2 Panacea Drugs Pvt. Ltd
2.2.1 Panacea Drugs Pvt. Ltd Details
2.2.2 Panacea Drugs Pvt. Ltd Major Business
2.2.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product and Services
2.2.4 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Panacea Drugs Pvt. Ltd Recent Developments/Updates
2.3 Shantha Biotechnics
2.3.1 Shantha Biotechnics Details
2.3.2 Shantha Biotechnics Major Business
2.3.3 Shantha Biotechnics Pentavalent Vaccine Product and Services
2.3.4 Shantha Biotechnics Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shantha Biotechnics Recent Developments/Updates
2.4 Biological E. Ltd.
2.4.1 Biological E. Ltd. Details
2.4.2 Biological E. Ltd. Major Business
2.4.3 Biological E. Ltd. Pentavalent Vaccine Product and Services
2.4.4 Biological E. Ltd. Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Biological E. Ltd. Recent Developments/Updates
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Pentavalent Vaccine Product and Services
2.5.4 Novartis AG Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis AG Recent Developments/Updates
2.6 Crucell
2.6.1 Crucell Details
2.6.2 Crucell Major Business
2.6.3 Crucell Pentavalent Vaccine Product and Services
2.6.4 Crucell Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Crucell Recent Developments/Updates
2.7 Bio Farma
2.7.1 Bio Farma Details
2.7.2 Bio Farma Major Business
2.7.3 Bio Farma Pentavalent Vaccine Product and Services
2.7.4 Bio Farma Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bio Farma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PENTAVALENT VACCINE BY MANUFACTURER
3.1 Global Pentavalent Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pentavalent Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Pentavalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pentavalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pentavalent Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Pentavalent Vaccine Manufacturer Market Share in 2022
3.5 Pentavalent Vaccine Market: Overall Company Footprint Analysis
3.5.1 Pentavalent Vaccine Market: Region Footprint
3.5.2 Pentavalent Vaccine Market: Company Product Type Footprint
3.5.3 Pentavalent Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Pentavalent Vaccine Market Size by Region
4.1.1 Global Pentavalent Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Pentavalent Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Pentavalent Vaccine Average Price by Region (2018-2029)
4.2 North America Pentavalent Vaccine Consumption Value (2018-2029)
4.3 Europe Pentavalent Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Pentavalent Vaccine Consumption Value (2018-2029)
4.5 South America Pentavalent Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Pentavalent Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Pentavalent Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Pentavalent Vaccine Consumption Value by Type (2018-2029)
5.3 Global Pentavalent Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Pentavalent Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Pentavalent Vaccine Consumption Value by Application (2018-2029)
6.3 Global Pentavalent Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Pentavalent Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Pentavalent Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Pentavalent Vaccine Market Size by Country
7.3.1 North America Pentavalent Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Pentavalent Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Pentavalent Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Pentavalent Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Pentavalent Vaccine Market Size by Country
8.3.1 Europe Pentavalent Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Pentavalent Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Pentavalent Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pentavalent Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pentavalent Vaccine Market Size by Region
9.3.1 Asia-Pacific Pentavalent Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pentavalent Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Pentavalent Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Pentavalent Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Pentavalent Vaccine Market Size by Country
10.3.1 South America Pentavalent Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Pentavalent Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Pentavalent Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pentavalent Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pentavalent Vaccine Market Size by Country
11.3.1 Middle East & Africa Pentavalent Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pentavalent Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Pentavalent Vaccine Market Drivers
12.2 Pentavalent Vaccine Market Restraints
12.3 Pentavalent Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Pentavalent Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pentavalent Vaccine
13.3 Pentavalent Vaccine Production Process
13.4 Pentavalent Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pentavalent Vaccine Typical Distributors
14.3 Pentavalent Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Pentavalent Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pentavalent Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Lyophilized
1.3.3 Liquid
1.4 Market Analysis by Application
1.4.1 Overview: Global Pentavalent Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Retail Pharmacy
1.4.3 Hospital Pharmacy
1.4.4 E-commerce
1.5 Global Pentavalent Vaccine Market Size & Forecast
1.5.1 Global Pentavalent Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pentavalent Vaccine Sales Quantity (2018-2029)
1.5.3 Global Pentavalent Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Serum Institute of India
2.1.1 Serum Institute of India Details
2.1.2 Serum Institute of India Major Business
2.1.3 Serum Institute of India Pentavalent Vaccine Product and Services
2.1.4 Serum Institute of India Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Serum Institute of India Recent Developments/Updates
2.2 Panacea Drugs Pvt. Ltd
2.2.1 Panacea Drugs Pvt. Ltd Details
2.2.2 Panacea Drugs Pvt. Ltd Major Business
2.2.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product and Services
2.2.4 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Panacea Drugs Pvt. Ltd Recent Developments/Updates
2.3 Shantha Biotechnics
2.3.1 Shantha Biotechnics Details
2.3.2 Shantha Biotechnics Major Business
2.3.3 Shantha Biotechnics Pentavalent Vaccine Product and Services
2.3.4 Shantha Biotechnics Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Shantha Biotechnics Recent Developments/Updates
2.4 Biological E. Ltd.
2.4.1 Biological E. Ltd. Details
2.4.2 Biological E. Ltd. Major Business
2.4.3 Biological E. Ltd. Pentavalent Vaccine Product and Services
2.4.4 Biological E. Ltd. Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Biological E. Ltd. Recent Developments/Updates
2.5 Novartis AG
2.5.1 Novartis AG Details
2.5.2 Novartis AG Major Business
2.5.3 Novartis AG Pentavalent Vaccine Product and Services
2.5.4 Novartis AG Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Novartis AG Recent Developments/Updates
2.6 Crucell
2.6.1 Crucell Details
2.6.2 Crucell Major Business
2.6.3 Crucell Pentavalent Vaccine Product and Services
2.6.4 Crucell Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Crucell Recent Developments/Updates
2.7 Bio Farma
2.7.1 Bio Farma Details
2.7.2 Bio Farma Major Business
2.7.3 Bio Farma Pentavalent Vaccine Product and Services
2.7.4 Bio Farma Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Bio Farma Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PENTAVALENT VACCINE BY MANUFACTURER
3.1 Global Pentavalent Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pentavalent Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Pentavalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pentavalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pentavalent Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Pentavalent Vaccine Manufacturer Market Share in 2022
3.5 Pentavalent Vaccine Market: Overall Company Footprint Analysis
3.5.1 Pentavalent Vaccine Market: Region Footprint
3.5.2 Pentavalent Vaccine Market: Company Product Type Footprint
3.5.3 Pentavalent Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Pentavalent Vaccine Market Size by Region
4.1.1 Global Pentavalent Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Pentavalent Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Pentavalent Vaccine Average Price by Region (2018-2029)
4.2 North America Pentavalent Vaccine Consumption Value (2018-2029)
4.3 Europe Pentavalent Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Pentavalent Vaccine Consumption Value (2018-2029)
4.5 South America Pentavalent Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Pentavalent Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Pentavalent Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Pentavalent Vaccine Consumption Value by Type (2018-2029)
5.3 Global Pentavalent Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Pentavalent Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Pentavalent Vaccine Consumption Value by Application (2018-2029)
6.3 Global Pentavalent Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Pentavalent Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Pentavalent Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Pentavalent Vaccine Market Size by Country
7.3.1 North America Pentavalent Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Pentavalent Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Pentavalent Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Pentavalent Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Pentavalent Vaccine Market Size by Country
8.3.1 Europe Pentavalent Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Pentavalent Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Pentavalent Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pentavalent Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pentavalent Vaccine Market Size by Region
9.3.1 Asia-Pacific Pentavalent Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pentavalent Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Pentavalent Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Pentavalent Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Pentavalent Vaccine Market Size by Country
10.3.1 South America Pentavalent Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Pentavalent Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Pentavalent Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pentavalent Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pentavalent Vaccine Market Size by Country
11.3.1 Middle East & Africa Pentavalent Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pentavalent Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Pentavalent Vaccine Market Drivers
12.2 Pentavalent Vaccine Market Restraints
12.3 Pentavalent Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Pentavalent Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pentavalent Vaccine
13.3 Pentavalent Vaccine Production Process
13.4 Pentavalent Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pentavalent Vaccine Typical Distributors
14.3 Pentavalent Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Pentavalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pentavalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 4. Serum Institute of India Major Business
Table 5. Serum Institute of India Pentavalent Vaccine Product and Services
Table 6. Serum Institute of India Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Serum Institute of India Recent Developments/Updates
Table 8. Panacea Drugs Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Panacea Drugs Pvt. Ltd Major Business
Table 10. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product and Services
Table 11. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Panacea Drugs Pvt. Ltd Recent Developments/Updates
Table 13. Shantha Biotechnics Basic Information, Manufacturing Base and Competitors
Table 14. Shantha Biotechnics Major Business
Table 15. Shantha Biotechnics Pentavalent Vaccine Product and Services
Table 16. Shantha Biotechnics Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Shantha Biotechnics Recent Developments/Updates
Table 18. Biological E. Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Biological E. Ltd. Major Business
Table 20. Biological E. Ltd. Pentavalent Vaccine Product and Services
Table 21. Biological E. Ltd. Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Biological E. Ltd. Recent Developments/Updates
Table 23. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 24. Novartis AG Major Business
Table 25. Novartis AG Pentavalent Vaccine Product and Services
Table 26. Novartis AG Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Novartis AG Recent Developments/Updates
Table 28. Crucell Basic Information, Manufacturing Base and Competitors
Table 29. Crucell Major Business
Table 30. Crucell Pentavalent Vaccine Product and Services
Table 31. Crucell Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Crucell Recent Developments/Updates
Table 33. Bio Farma Basic Information, Manufacturing Base and Competitors
Table 34. Bio Farma Major Business
Table 35. Bio Farma Pentavalent Vaccine Product and Services
Table 36. Bio Farma Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bio Farma Recent Developments/Updates
Table 38. Global Pentavalent Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Pentavalent Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Pentavalent Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Pentavalent Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Pentavalent Vaccine Production Site of Key Manufacturer
Table 43. Pentavalent Vaccine Market: Company Product Type Footprint
Table 44. Pentavalent Vaccine Market: Company Product Application Footprint
Table 45. Pentavalent Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Pentavalent Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Pentavalent Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Pentavalent Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Pentavalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Pentavalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Pentavalent Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Pentavalent Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Pentavalent Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Pentavalent Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Pentavalent Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Pentavalent Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Pentavalent Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Pentavalent Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Pentavalent Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Pentavalent Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Pentavalent Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Pentavalent Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Pentavalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Pentavalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Pentavalent Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Pentavalent Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Pentavalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Pentavalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Pentavalent Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Pentavalent Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Pentavalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Pentavalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Pentavalent Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Pentavalent Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Pentavalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Pentavalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Pentavalent Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Pentavalent Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Pentavalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Pentavalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Pentavalent Vaccine Raw Material
Table 106. Key Manufacturers of Pentavalent Vaccine Raw Materials
Table 107. Pentavalent Vaccine Typical Distributors
Table 108. Pentavalent Vaccine Typical Customers
Table 1. Global Pentavalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pentavalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 4. Serum Institute of India Major Business
Table 5. Serum Institute of India Pentavalent Vaccine Product and Services
Table 6. Serum Institute of India Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Serum Institute of India Recent Developments/Updates
Table 8. Panacea Drugs Pvt. Ltd Basic Information, Manufacturing Base and Competitors
Table 9. Panacea Drugs Pvt. Ltd Major Business
Table 10. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product and Services
Table 11. Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Panacea Drugs Pvt. Ltd Recent Developments/Updates
Table 13. Shantha Biotechnics Basic Information, Manufacturing Base and Competitors
Table 14. Shantha Biotechnics Major Business
Table 15. Shantha Biotechnics Pentavalent Vaccine Product and Services
Table 16. Shantha Biotechnics Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Shantha Biotechnics Recent Developments/Updates
Table 18. Biological E. Ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Biological E. Ltd. Major Business
Table 20. Biological E. Ltd. Pentavalent Vaccine Product and Services
Table 21. Biological E. Ltd. Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Biological E. Ltd. Recent Developments/Updates
Table 23. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 24. Novartis AG Major Business
Table 25. Novartis AG Pentavalent Vaccine Product and Services
Table 26. Novartis AG Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Novartis AG Recent Developments/Updates
Table 28. Crucell Basic Information, Manufacturing Base and Competitors
Table 29. Crucell Major Business
Table 30. Crucell Pentavalent Vaccine Product and Services
Table 31. Crucell Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Crucell Recent Developments/Updates
Table 33. Bio Farma Basic Information, Manufacturing Base and Competitors
Table 34. Bio Farma Major Business
Table 35. Bio Farma Pentavalent Vaccine Product and Services
Table 36. Bio Farma Pentavalent Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Bio Farma Recent Developments/Updates
Table 38. Global Pentavalent Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Pentavalent Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Pentavalent Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Pentavalent Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Pentavalent Vaccine Production Site of Key Manufacturer
Table 43. Pentavalent Vaccine Market: Company Product Type Footprint
Table 44. Pentavalent Vaccine Market: Company Product Application Footprint
Table 45. Pentavalent Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Pentavalent Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Pentavalent Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Pentavalent Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Pentavalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Pentavalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Pentavalent Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Pentavalent Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Pentavalent Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Pentavalent Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Pentavalent Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Pentavalent Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Pentavalent Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Pentavalent Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Pentavalent Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Pentavalent Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Pentavalent Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Pentavalent Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Pentavalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Pentavalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Pentavalent Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Pentavalent Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Pentavalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Pentavalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Pentavalent Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Pentavalent Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Pentavalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Pentavalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Pentavalent Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Pentavalent Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Pentavalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Pentavalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Pentavalent Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Pentavalent Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Pentavalent Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Pentavalent Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Pentavalent Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Pentavalent Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Pentavalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Pentavalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Pentavalent Vaccine Raw Material
Table 106. Key Manufacturers of Pentavalent Vaccine Raw Materials
Table 107. Pentavalent Vaccine Typical Distributors
Table 108. Pentavalent Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Pentavalent Vaccine Picture
Figure 2. Global Pentavalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pentavalent Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Lyophilized Examples
Figure 5. Liquid Examples
Figure 6. Global Pentavalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pentavalent Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Retail Pharmacy Examples
Figure 9. Hospital Pharmacy Examples
Figure 10. E-commerce Examples
Figure 11. Global Pentavalent Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Pentavalent Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Pentavalent Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Pentavalent Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Pentavalent Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Pentavalent Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Pentavalent Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Pentavalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Pentavalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Pentavalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Pentavalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Pentavalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Pentavalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Pentavalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Pentavalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Pentavalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Pentavalent Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Pentavalent Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Pentavalent Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Pentavalent Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Pentavalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Pentavalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Pentavalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Pentavalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Pentavalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Pentavalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Pentavalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Pentavalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Pentavalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Pentavalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Pentavalent Vaccine Market Drivers
Figure 74. Pentavalent Vaccine Market Restraints
Figure 75. Pentavalent Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Pentavalent Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Pentavalent Vaccine
Figure 79. Pentavalent Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Pentavalent Vaccine Picture
Figure 2. Global Pentavalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pentavalent Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Lyophilized Examples
Figure 5. Liquid Examples
Figure 6. Global Pentavalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pentavalent Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Retail Pharmacy Examples
Figure 9. Hospital Pharmacy Examples
Figure 10. E-commerce Examples
Figure 11. Global Pentavalent Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Pentavalent Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Pentavalent Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Pentavalent Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Pentavalent Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Pentavalent Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Pentavalent Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Pentavalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Pentavalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Pentavalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Pentavalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Pentavalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Pentavalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Pentavalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Pentavalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Pentavalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Pentavalent Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Pentavalent Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Pentavalent Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Pentavalent Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Pentavalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Pentavalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Pentavalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Pentavalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Pentavalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Pentavalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Pentavalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Pentavalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Pentavalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Pentavalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Pentavalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Pentavalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Pentavalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Pentavalent Vaccine Market Drivers
Figure 74. Pentavalent Vaccine Market Restraints
Figure 75. Pentavalent Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Pentavalent Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Pentavalent Vaccine
Figure 79. Pentavalent Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
